Skip to main content
Erschienen in: Reactions Weekly 1/2020

01.08.2020 | Case report

Dasatinib

Acquired T315I mutation: 5 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Li X-Y, et al. An oral, chemotherapy-free regimen (dasatinib plus prednisone) as induction and consolidation for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia. British Journal of Haematology 189: e231-e234, No. 6, Jun 2020. Available from: URL: http://doi.org/10.1111/bjh.16661 Li X-Y, et al. An oral, chemotherapy-free regimen (dasatinib plus prednisone) as induction and consolidation for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia. British Journal of Haematology 189: e231-e234, No. 6, Jun 2020. Available from: URL: http://​doi.​org/​10.​1111/​bjh.​16661
Metadaten
Titel
Dasatinib
Acquired T315I mutation: 5 case reports
Publikationsdatum
01.08.2020
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2020
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-020-81434-7

Weitere Artikel der Ausgabe 1/2020

Reactions Weekly 1/2020 Zur Ausgabe

Case report

Multiple drugs

Case report

Treprostinil